Search results
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 2 days agoJN.1 emerged in the U... and Prevention. Natalie Thornburg, a research microbiologist at the CDC, said at Wednesday’s meeting that the coronavirus...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
KSAN - KLST San Angelo· 2 days agoWASHINGTON (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving cor…
Covid will still be here this summer. Will anyone care?
Washington Post via Yahoo News· 7 days agoCorrection: A previous version of this article said the CDC revised its covid quarantine protocols...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Scripps News via AOL· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA Panel OKs New COVID Vaccine for Fall | FOX 28 Spokane
FOX 28 Spokane· 1 day agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KRCG· 1 day agoGovernment advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Midland Reporter-Telegram· 2 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 5 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WSB Radio· 2 days agoWASHINGTON — (AP) — Government advisers Wednesday said it’s time to update the recipe for the...
FDA advisers back updating COVID shots to target JN.1 virus family
BioPharma Dive via Yahoo Finance· 1 day agoThe unanimous recommendation from the panel should help Novavax, which would have had difficulty...